🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate safety and tolerability of arbaclof...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00817986
Treatments Being Tested
This is a multicenter, randomized (1:1:1), double-blind, active and placebo...
Status
Completed
Location
Osmotica Study Site-138
Start Date
2012-11
Trial ID
NCT01743651
Treatments Being Tested
AIMS-2-CT-01 is a randomized, double-blind, placebo controlled, study to ex...
Status
Completed
Location
Robert Debré Hospital
Start Date
2019-09-19
Trial ID
NCT03682978
Treatments Being Tested
Clinical protocol OS440-3003 is a multicenter, open-label, non-randomized, ...
Status
Completed
Location
Osmotica Study Site-154
Start Date
2013-04
Trial ID
NCT01844232
Treatments Being Tested
Spasticity is a common complication in MS and occurs in up to 84% of patien...
Status
Completed
Location
Neuro Pain Medical Center
Start Date
2018-04-03
Trial ID
NCT03319732
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of treatment w...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00557973
Treatments Being Tested
To evaluate efficacy and safety of treatment with XP19986 Sustained Release...
Status
Completed
Location
MDS Pharma Services
Start Date
2007-11
Trial ID
NCT00557401
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of arbaclof...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00838396
Treatments Being Tested
The purpose of the study is to evaluate efficacy and safety of arbaclofen p...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00978016